FDA approves 1st rapid-acting insulin
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results